Mark A. Hillman
Hillman Value Fund
Mark A. Hillman CVS Health Corp stake
total: 76
Hillman Value Fund CVS trades
- Total transactions:
- 11
- New positions:
- 1
- Added:
- 4
- Reduced:
- 6
- Held since:
- 2020 Q1
- Held for:
- 26 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Mark A. Hillman holds 23,500 CVS Health Corp (CVS) shares with a market value of roughly $2.43M accounting for 3.11% of the overall portfolio. To date, the estimated cost basis is nearly $64.74 for "buy" trades and estimated average "sell" price is $79.48. Hillman Value Fund first purchased CVS in 2020 Q1, initially acquiring 40,000 shares. Since the initial investment in CVS Health Corp (CVS), Hillman Value Fund has made 10 more transactions.
When did Mark A. Hillman buy CVS Health Corp (CVS)?
Mark A. Hillman first invested in CVS Health Corp (CVS) in 2020 Q1 at the reported quarter-end price of $59.33 per share.
What's the cost basis of Hillman Value Fund's CVS stake?
The estimated cost basis for CVS Health Corp (CVS) stake is around $64.74 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $64.74
- Weighted AVG sell price:
- $79.48
Mark A. Hillman's historical trades in CVS Health Corp
11 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
3.11%
|
23,500
|
$103.45
|
$2,431,075
|
-25.40% (-8,000)
|
-1%
|
|
2025 Q4
|
2.67%
|
31,500
|
$79.36
|
$2,499,840
|
-13.22% (-4,800)
|
-0.36%
|
|
2025 Q3
|
2.60%
|
36,300
|
$75.39
|
$2,736,657
|
-21.43% (-9,900)
|
-0.63%
|
|
2025 Q2
|
2.69%
|
46,200
|
$68.98
|
$3,186,876
|
-12.99% (-6,900)
|
-0.33%
|
|
2025 Q1
|
2.53%
|
53,100
|
$67.75
|
$3,597,525
|
-35.24% (-28,900)
|
-0.93%
|
|
2023 Q3
|
2.75%
|
82,000
|
$69.82
|
$5,725,240
|
+26.15% (+17,000)
|
+0.57%
|
|
2022 Q1
|
2.67%
|
65,000
|
$101.21
|
$6,578,650
|
-15.58% (-12,000)
|
-0.52%
|
|
2021 Q1
|
3.35%
|
77,000
|
$75.23
|
$5,792,710
|
+22.22% (+14,000)
|
+0.61%
|
|
2020 Q4
|
3.27%
|
$68.30
|
+26.00% (+13,000)
|
|||
|
2020 Q3
|
2.81%
|
$58.40
|
+25.00% (+10,000)
|
|||
|
2020 Q1
|
3.31%
|
$59.33
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.